NCT04700332View on ClinicalTrials.gov

PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

July 15, 2022

Study Completion Date

December 15, 2022

Conditions
Prostate Cancer
Interventions
DRUG

DCFPyL PET/CT

Prostate Membrane Specific Antigen-specific imaging

Trial Locations (1)

92618

RECRUITING

Hoag Memorial Hospital Presbyterian, Irvine

All Listed Sponsors
lead

Hoag Memorial Hospital Presbyterian

OTHER